These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34998206)

  • 41. OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study.
    Kandimalla R; Wang W; Yu F; Zhou N; Gao F; Spillman M; Moukova L; Slaby O; Salhia B; Zhou S; Wang X; Goel A
    Clin Cancer Res; 2021 Aug; 27(15):4277-4286. PubMed ID: 34035068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.
    Pisanic TR; Cope LM; Lin SF; Yen TT; Athamanolap P; Asaka R; Nakayama K; Fader AN; Wang TH; Shih IM; Wang TL
    Clin Cancer Res; 2018 Dec; 24(24):6536-6547. PubMed ID: 30108103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
    Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E
    J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
    Taylor DD; Gercel-Taylor C
    Gynecol Oncol; 2008 Jul; 110(1):13-21. PubMed ID: 18589210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. mRNA, lncRNA and Circular RNA Expression Profiles in Granulosa Cells of Infertile Women with Ovarian Endometriosis.
    Guo J; Zeng H; Li T; Liang X; Peng J
    Reprod Sci; 2022 Oct; 29(10):2937-2946. PubMed ID: 35799021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
    Yoshioka Y; Katsuda T; Ochiya T
    Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
    Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
    J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment.
    Davies M; Davey MG; Miller N
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. microRNAs as biomarkers of ovarian cancer.
    Zhang H; Lu B
    Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
    [No Abstract]   [Full Text] [Related]  

  • 54. Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study.
    Horie K; Nanashima N; Yokoyama Y; Yoshioka H; Watanabe J
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers.
    Trinidad CV; Tetlow AL; Bantis LE; Godwin AK
    Cancer Prev Res (Phila); 2020 Mar; 13(3):241-252. PubMed ID: 32132118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating RNAs in prostate cancer patients.
    Mugoni V; Ciani Y; Nardella C; Demichelis F
    Cancer Lett; 2022 Jan; 524():57-69. PubMed ID: 34656688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment.
    Boerrigter E; Benoist GE; van Oort IM; Verhaegh GW; van Hooij O; Groen L; Smit F; Oving IM; de Mol P; Smilde TJ; Somford DM; Mehra N; Schalken JA; van Erp NP
    Mol Oncol; 2021 Sep; 15(9):2453-2465. PubMed ID: 33650292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.
    Li P; Liu S; Du L; Mohseni G; Zhang Y; Wang C
    Clin Epigenetics; 2022 Sep; 14(1):118. PubMed ID: 36153611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.